Thu, April 8, 2021
Wed, April 7, 2021
Tue, April 6, 2021
Mon, April 5, 2021
Sun, April 4, 2021
Thu, April 1, 2021
Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021

Robyn Karnauskas Maintained (BTAI) at Strong Buy with Decreased Target to $127 on, Apr 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-127-on-apr-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robyn Karnauskas of Truist Securities, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $150 to $127 on, Apr 1st, 2021.

Robyn has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Robyn's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robyn


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $99 on, Monday, February 1st, 2021

Publication Contributing Sources